.

EDITOR-IN-CHIEF
I. Yakoub-Agha, Professor, Dept. of Haematology, Head of the Immune Cellular Therapy Unit, Lille University Hospital, Lille, France

EDITORS

T. Alsuliman, Doctor, Dept. of Haematology and cellular therapy, Saint-Antoine hospital, APHP, Paris ; Sorbonne University, Paris, France

M. Beksac, Professor, Dept. of Hematology, Ankara University, Ankara, Turkey
H. Bönig, Professor, Dept of Translational Development of Cellular Therapeutics, Institute for Transfusion Medicine and Immune Hematology, Johann-Wolfgang-Goethe Medical University, Frankfurt, Germany
E. Brissot, Doctor, Dept. of Haematology and cellular therapy, Saint-Antoine hospital, APHP, Paris ; Sorbonne University, Paris, France
G. Damaj, Professor, Dept. of Haematology, Caen University Hospital, Caen, France

R. Greco, Doctor, Blood and Marrow Transplant Unit (BMT), San Raffaele Scientific Hospital (IRCCS), Milano, Italy
M. Guzman, Professor, Division of Hematology - Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, USA
P. Hayden, Doctor, Dept. of Haematology, St. James's hospital, Dublin, Ireland
D. Humaidan, Doctor, Dept. of Cognitive Modeling, Eberhard Karls University of Tuebingen and Max Planck International Research School for Intelligent Systems (IMPRS-IS), Tuebingen, Germany
M. Ahmad Kassab, Research Associate, University of Pennsylvanian, Philadelphia, Pennsylvania, USA
M. Labalette, Professor, Lab of Immunology and HLA, Lille University Hospital, Lille, France
J. Larghero, Professor, Saint Louis Hospital, Paris, France
J. J. Melenhorst, Professor, University of Pennsylvania, Philadelphia, United States

C. Roddie, Doctor, University of London, London, UK
J. A Snowden, Professor, Consultant Haematologist & Director of Blood and Marrow Transplantation, Sheffi eld Teaching Hospitals NHS Foundation Trust Sheffi eld, UK

M. Subklewe, Professor, LMU University Hospital Munich, Munich, Germany

A. Sureda, Doctor, Blood Cell Barcelona Hematology Institute, Barcelona, Spain

.

BIOSTATISTICIAN

M. Ordak, Centre for Preclinical, Research and Technology (CePT), Medical University of Warsaw, Poland

.

INTERNATIONAL SCIENTIFIC COMMITTEE

R. Burt (Northwestern University Feinberg School of Medicine, Chicago, United States), F. Calvo (INSERM U749, Villejuif, France), O. Cohen Haguenauer (University Institute of Geriatry of Sherbrooke, Paris, France), T. Fülop (Sherbrooke University of Applied Sciences Institute, Quebec, Canada), M.-P. Jacob-Lenet (INSERM, Cardiovascular Structural Diseases, Paris, France), M. Leboyer (University Hospital Centre Henri Mondor, Créteil, France), F.-X. Maquart (University Hospital Centre Reims Biochemistry Laboratory, Reims, France), J.-M. Molina (Saint Louis Hospital, Paris, France), J.-C. Monboisse (University Hospital Centre Reims Biochemistry Laboratory, Reims, France), N. Mazure (Nice, France)